Home › Research › Disease mechanisms
Clinicopathological features of primary tauopathies: a brain bank series
Brigid Ryan, Laura Marriott, Helen C. Murray, Richard L. M. Faull, Clinton P. Turner, Maurice A. Curtis. Frontiers in Neurology, 2026-03-30
Topic: Brain proteins, microglia and lab models
Plain-language summary
Fifteen cases were identified, spanning argyrophilic grain disease, primary age-related tauopathy, corticobasal degeneration, genetic frontotemporal dementia, and progressive supranuclear palsy. The mean age of onset was 69 years, with average survival of 6 years. Notably, only 47% of cases showed concordance between clinical and pathological diagnosis, underscoring diagnostic challenges. Neuropathological review revealed marked diversity in tau pathology and regional vulnerability, with most cases demonstrating both neuronal and glial tau pathology. This case series highlights the complexity and heterogeneity of primary tauopathies and the critical role of post-mortem neuropathological examination for diagnosis. By making fixed and frozen tissue, and clinical data available for national and international dissemination, this study provides a valuable resource to advance global research into the pathogenesis and classification of tauopathies. Furthermore, this work highlights the important role of brain banking in the study of rare diseases.
What this study adds
Evidence grade: Low
In this brain bank series of 15 cases, only 47% showed agreement between clinical and pathological diagnosis, showing how hard these diseases are to diagnose in life. The study provides tissue and clinical data for research, but does not test any treatment, cure or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Ryan, B., Marriott, L., Murray, H. C., Faull, R. L. M., Turner, C. P., & Curtis, M. A. (2026). Clinicopathological features of primary tauopathies: a brain bank series. Frontiers in Neurology. https://doi.org/10.3389/fneur.2026.1768959
Vancouver
Ryan B, Marriott L, Murray HC, Faull RLM, Turner CP, Curtis MA. Clinicopathological features of primary tauopathies: a brain bank series. Frontiers in Neurology. 2026. doi:10.3389/fneur.2026.1768959. PMID: 41982423.
BibTeX
@article{ryan2026-41982423,
author = {Ryan, Brigid and Marriott, Laura and Murray, Helen C. and Faull, Richard L. M. and Turner, Clinton P. and Curtis, Maurice A.},
title = {{Clinicopathological features of primary tauopathies: a brain bank series}},
journal = {Frontiers in Neurology},
year = {2026},
doi = {10.3389/fneur.2026.1768959},
pmid = {41982423},
url = {https://doi.org/10.3389/fneur.2026.1768959}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Fifteen cases were identified, spanning argyrophilic grain disease, primary age-related tauopathy, corticobasal degeneration, genetic frontotemporal dementia, and progressive supranuclear palsy.
- The mean age of onset was 69 years, with average survival of 6 years.
- Notably, only 47% of cases showed concordance between clinical and pathological diagnosis, underscoring diagnostic challenges.
- Neuropathological review revealed marked diversity in tau pathology and regional vulnerability, with most cases demonstrating both neuronal and glial tau pathology.
- This case series highlights the complexity and heterogeneity of primary tauopathies and the critical role of post-mortem neuropathological examination for diagnosis.
Why it matters
In this brain bank series of 15 cases, only 47% showed agreement between clinical and pathological diagnosis, showing how hard these diseases are to diagnose in life. The study provides tissue and clinical data for research, but does not test any treatment, cure or prevention.
Study details
- Evidence strengthLow
How this study scored 38/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Frontiers in Neurology) |
| Journal's citation record | 2 / 4 | Frontiers in Neurology: journal h-index 162 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 3 / 6 | Cited 4.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Maurice A. Curtis: h-index 52 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Auckland: institution h-index 788 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41982423) |
| Free to read | 2 / 2 | Free to read |
| Total | 38 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3389/fneur.2026.1768959
- PubMed: 41982423
- Original source →
- Free full text: Frontiers in Neurology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Disease mechanisms from nearby years
Also tagged “phosphorylated”
732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.